Últimos Artículos de Diabetes, Obesity and Metabolism
- Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial
- Efficacy and safety of PEGylated uricase in healthy adults and patients with hyperuricaemia: A phase I, randomized, double‐blind, dose‐escalation, placebo‐controlled trial
- Association between estimated glucose disposal rate and lower extremity arterial disease in type 2 diabetes: A nationwide cross‐sectional study from China
- Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis
- Genomic risk prediction for type 2 diabetes in Australian individuals aged 70 years and older
- Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
- Exploring population and sex‐specific disease trajectories for multimorbidities among individuals with overweight or obesity: A retrospective cohort study in UK biobank
- A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank
- A1c versus oral glucose tolerance test for chronic glycemic surveillance in women with previous gestational diabetes
- Type 2 diabetes and depression via microvascular dysfunction, neurodegeneration, inflammation, advanced glycation end products (AGEs), and arterial stiffness
- Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12 months
- Long‐term efficacy of autologous cell therapy, repeated PTA and conservative treatment in people with diabetes and chronic limb‐threatening ischaemia
- Gestational diabetes risk associated with early pregnancy blood pressure characteristics and trajectories: A Chinese prospective cohort study
- Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
- Get ahead of the disease: Islet cell autoimmunity and preclinical phase of type 1 diabetes in general population of 1–9 year‐old children in the north‐eastern region of Poland—A summary of the first 18 months of the study
- A study on the utilization of canagliflozin in type 1 diabetes mellitus using real‐world data from four European countries
- Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed‐loop system (Omnipod® 5) in adults with type 1 diabetes
- Mediterranean diet vs. the Australian guide to healthy eating (AGHE) on body composition and glucose metabolism: A randomized controlled trial
- Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study
- Incretin‐based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta‐analysis of randomized controlled trials